Breadcrumb

By the Numbers

Image
  • 333Open Clinical Trials
  • 57New Clinical Trials
  • 1,351New Patients
Image
  • 239Principal Investigators
  • 8New Faculty Recruits
  • 3Newly Tenured Investigators
  • 303Staff Scientists/Staff Clinicians
  • 480Technical Lab Staff
  • 773Postdoctoral/Clinical Fellows
  • 401Postbaccalaureate/Predoctoral Students
Image
  • >1,100Articles in Peer-Reviewed Journals
Image
  • 52Technology Facilities and Platforms
Image
Covid
  • >50COVID-19 Projects
  • >140COVID-19 Publications

Technology Transfer Activities

Image
  • 63New Employee Invention Reports
  • 52Issued U.S. Patents
  • 21New Cooperative Research and Development Agreements (CRADAs)
  • 9New Clinical CRADAs
  • 171Active CRADAs
  • 84Clinical CRADAs
  • 6Umbrella CRADAs
  • 24New Clinical Trial Agreements (CTAs)
  • 105Active CTAs
Image
  • 102New Licenses for CCR Technologies
  • 655Active Licenses
Image
  • 4FDA Approvals
  • 1FDA Orphan Drug Designation

The NCI Technology Transfer Center (TTC) works to enable and guide collaboration, invention development and licensing to advance today’s discoveries into tomorrow’s medical care. The TTC supports technology development activities for NCI in therapeutics, diagnostics, research tools, vaccines, devices, software and facilitates partnerships with outside organizations so that NCI discoveries can reach the public in a timely manner.

For information on licensing and co-development opportunities, contact the TTC Invention Development and Marketing Unit (ncitechtransfer@mail.nih.gov).